CD40L-HYPERIGM SYNDROME

Clinical trials for CD40L-HYPERIGM SYNDROME explained in plain language.

Never miss a new study

Get alerted when new CD40L-HYPERIGM SYNDROME trials appear

Sign up with your email to follow new studies for CD40L-HYPERIGM SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

First-of-its-Kind gene editing trial aims to cure devastating immune disease

⭐️ CURE ⭐️ Recruiting now

This study is testing a new gene therapy for a single patient with a rare and serious inherited immune disorder called CD40L-HyperIgM syndrome. Doctors will use a precise gene-editing tool to fix the patient's own blood stem cells and immune cells, then infuse them back after a m…

Matched conditions: CD40L-HYPERIGM SYNDROME

Phase: PHASE1, PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: ⭐️ CURE ⭐️

Last updated Mar 13, 2026 15:06 UTC

CD40L-HYPERIGM SYNDROME

Get alerted when new CD40L-HYPERIGM SYNDROME trials appear

First-of-its-Kind gene editing trial aims to cure devastating immune disease